---
title: "Shanghai Model Organisms Center, Inc. (688265.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688265.SH.md"
symbol: "688265.SH"
name: "Shanghai Model Organisms Center, Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-21T11:47:54.895Z"
locales:
  - [en](https://longbridge.com/en/quote/688265.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688265.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688265.SH.md)
---

# Shanghai Model Organisms Center, Inc. (688265.SH)

## Company Overview

Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, and nervous system diseases, cardio-metabolic, autoimmune, and spontaneous tumor; and target humanized knockins, which includes tumor targets, immune checkpoint, complements, cytokines, and metabolic and other targets, as well as cytokine reporters, inducible cell ablation, and cell-specific reporters.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.modelorg.com](https://www.modelorg.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: B (0.38)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 14 / 26 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.85% |  |
| Net Profit YoY | 79.57% |  |
| P/B Ratio | 1.78 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3034731802.90 |  |
| Revenue | 431713778.07 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 1.95% | C |
| Profit Margin | 7.65% | B |
| Gross Margin | 53.96% | B |
| Revenue YoY | 11.85% | B |
| Net Profit YoY | 79.57% | A |
| Total Assets YoY | 2.86% | C |
| Net Assets YoY | 1.76% | C |
| Cash Flow Margin | 266.84% | A |
| OCF YoY | 11.85% | B |
| Turnover | 0.22 | D |
| Gearing Ratio | 12.87% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai Model Organisms Center, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.85%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "79.57%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.78",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3034731802.90",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "431713778.07",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "1.95%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "7.65%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "53.96%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "11.85%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "79.57%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.86%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "1.76%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "266.84%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "11.85%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.22",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "12.87%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 91.90 | 14/26 | 130.81 | 92.82 | 69.60 |
| PB | 1.78 | 2/26 | 2.25 | 2.00 | 1.75 |
| PS (TTM) | 7.03 | 15/26 | 9.33 | 8.12 | 7.36 |
| Dividend Yield | 0.00% | - | 0.47% | 0.45% | 0.40% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688265.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688265.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688265.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**